A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia
Clinical trial NCT01051531 · COMPLETED
Trial details
- NCT number
- NCT01051531
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-22
- Primary completion
- 2013-05-17
- Enrollment
- 546
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.